Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?

Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?

Bibliographic Details
Main Authors:	Fabrice Uhel, Brendon P. Scicluna, Lonneke A. van Vught, Olaf L. Cremer, Marc J. Bonten, Marcus J. Schultz, Tom van der Poll
Format:	Article
Language:	English
Published:	BMC 2019-06-01
Series:	Critical Care
Subjects:	Sepsis Pneumonia Biomarker Matrix metalloproteinase-8 Procalcitonin Infection
Online Access:	http://link.springer.com/article/10.1186/s13054-019-2513-7

Similar Items

Association between delay in intensive care unit admission and the host response in patients with community-acquired pneumonia
by: Liza Pereverzeva, et al.
Published: (2021-09-01)

Metalloproteinase and tissue inhibitor of metalloproteinase in tuberculosis and malignant pleural effusion
by: Nesriene Mohamad El Margoushy, et al.
Published: (2013-04-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

The impact of changes in serum levels of metalloproteinase-2 and metalloproteinase-9 on pain perception in patients with disc herniation before and after surgery
by: Kamieniak P, et al.
Published: (2019-05-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)

Serum Procalcitonin Levels on Admission Predict Death in Severe and Critical COVID-19 Patients in Wuhan, China
by: Han Jin, MD, et al.
Published: (2020-09-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Procalcitonin for detecting community-acquired bacterial pneumonia
by: Devi Gusmaiyanto, et al.
Published: (2015-04-01)

Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis
by: Qian Li, et al.
Published: (2016-04-01)

Expressions of matrix metalloproteinase-2 and extracellular matrix metalloproteinase inducer in retinoblastoma
by: Yu-Hong Cheng, et al.
Published: (2015-07-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Association between expression of tissue inhibitors of metalloproteinases-1, matrix metalloproteinase-2, and matrix metalloproteinase-9 genes and axillary lymph nodes metastasis in patients with breast cancer
by: Alireza Abdollahi, et al.
Published: (2019-01-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Are matrix metalloproteinases the missing link?
by: F Mannello, et al.
Published: (2005-05-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Diagnostic Performance of Procalcitonin for the Early Identification of Sepsis in Patients with Elevated qSOFA Score at Emergency Admission
by: Myrto Bolanaki, et al.
Published: (2021-08-01)

The Regulatory Role Of Matrix Metalloproteinases In T Cell Activation
by: Benson, Heather Lynette
Published: (2009)

A STUDY ON THE CLINICAL RELEVANCE OF METALLOPROTEINASE INHIBITION

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019-01-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Sub-Cellular Localization of Metalloproteinases in Megakaryocytes
by: Alessandro Malara, et al.
Published: (2018-07-01)

Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery
by: Mohamed M Abu Elyazed, et al.
Published: (2017-04-01)

Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
by: Maryam Raeeszadeh-Sarmazdeh, et al.
Published: (2020-05-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
by: Qiao Zhen-kui, et al.
Published: (2013-01-01)

Matrix Metalloproteinases in Health and Disease
by: Raffaele Serra
Published: (2020-08-01)

Evaluation of the Effects of Increased Parathyroid Hormone (PTH) Following Myocardial Infarction on the Expressions Level of Matrix Metalloproteinase 9 and Tissue Inhibitor Metalloproteinase
by: Faezeh Hoseini, et al.
Published: (2017-11-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Snake Venom Metalloproteinases (SVMPs): A structure-function update
by: Olamide Tosin Olaoba, et al.
Published: (2020-09-01)

Procalcitonin and CRP as biomarkers in discrimination of community-acquired pneumonia and exacerbation of COPD
by: Ayfer Çolak A., et al.
Published: (2017-01-01)

The role of matrix metalloproteinases in early and late gonarthrosis manifestations
by: Ekaterina V. Gladkova
Published: (2020-09-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

Matrix Metalloproteinases in Diabetic Kidney Disease
by: Nuria Garcia-Fernandez, et al.
Published: (2020-02-01)

Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation
by: Thomas Fischer, et al.
Published: (2019-06-01)

Matrix metalloproteinases and atherosclerosis
by: Piotr Fic, et al.
Published: (2011-01-01)

Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
by: Duda Izabela, et al.
Published: (2020-03-01)

Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases
by: Stefano Pluda, et al.
Published: (2021-07-01)

Relationship between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity
by: Pelin Uysal, et al.
Published: (2019-02-01)